From $139/mo
Tirzepatide
Weekly and dual-action. Care, coaching and shipping included. On a 12-month plan; $169/mo month to month.
Get startedHome / Tirzepatide results timeline
What to expect.
Tirzepatide results timeline: what to expect, month by month
Medically reviewed by the NexLife clinical team, led by Adam Kennah, MD (NPI 1144260043) · Updated
Tirzepatide starts at 2.5 mg and steps up every 4 weeks or more, so the first months are about adjusting. In the 72-week SURMOUNT-1 trial of Zepbound, average weight loss was 15.0% to 20.9% depending on dose, and 9 in 10 people on 15 mg lost at least 5%. People who stopped after 36 weeks regained 14.0% over the next year. At NexLife, compounded tirzepatide is $139 a month on a 12-month plan, or $169 month to month, the same at every dose, matched if you pay less†.
From $139/mo at every dosePrice Match Guarantee†
- Weeks 1–20: starting dose, then steps every 4+ weeks
- Week 72: 15.0% to 20.9% average loss, by dose
- Stopping: 14.0% regained over the next year, on average
Published by NexLifeLegitScript-certifiedUpdated Medically reviewed by the NexLife clinical team, led by Adam Kennah, MD (NPI 1144260043)
Milestones from the trials
- Weeks 1–4
- 2.5 mg, the starting dose
- Weeks 5–20
- Stepping up, 2.5 mg every 4+ weeks
- Weeks 21–72
- Maintenance, at least 52 weeks in Study 1
- Week 72
- −15.0% to −20.9%, average by dose (Study 1)
Questions about your progress? Call or text
Check my eligibility, from $139/mo
4.8 out of 5 on Trustpilot · LegitScript certified
Compounded medicines aren’t FDA-approved. A NexLife provider prescribes one only if it offers a significant difference for you compared with an FDA-approved medicine.
The timeline
Tirzepatide results timeline, month by month
From the Zepbound prescribing information. Your own pace depends on your dose, your body and your habits.
Getting started. 2.5 mg a week, a starting dose that isn’t meant for the long term. It takes about 4 weeks for blood levels to settle on a dose. Stomach side effects are most likely while the dose is going up.
Stepping up. The dose can rise by 2.5 mg after at least 4 weeks at each step. The earliest 15 mg can start is week 21. Your provider sets the pace; some people stay longer at a dose.
At your maintenance dose. In Study 1, people spent at least 52 weeks on their maintenance dose (5, 10 or 15 mg) before results were measured at week 72.
The trial endpoint. In Study 1, average loss was 15.0% on 5 mg, 19.5% on 10 mg and 20.9% on 15 mg, versus 3.1% on placebo.
What Study 4 found. People who took it for 36 weeks and were then switched to placebo regained 14.0% of their weight over the next 52 weeks; those who kept taking it lost another 5.5%.
Milestones
How many people reached each milestone
| Weight lost | Placebo | 5 mg | 10 mg | 15 mg |
|---|---|---|---|---|
| 5% or more | 34.5% | 85.1% | 88.9% | 90.9% |
| 10% or more | 18.8% | 68.5% | 78.1% | 83.5% |
| 15% or more | 8.8% | 48.0% | 66.6% | 70.6% |
| 20% or more | 3.1% | 30.0% | 50.1% | 56.7% |
Zepbound label, Table 2. These numbers come from trials of FDA-approved Zepbound. Compounded tirzepatide isn’t FDA-approved and wasn’t studied in them.
- 9 in 10on 15 mg lost at least 5%
- More than halfon 15 mg lost at least 20%
- 3.1%average loss on placebo
Your number
Put the averages in pounds
–Enter your starting weight in pounds.
Uses SURMOUNT-1 averages at 72 weeks for FDA-approved Zepbound (15.0% at 5 mg, 19.5% at 10 mg, 20.9% at 15 mg). Averages describe a group, not a person. Compounded tirzepatide wasn’t studied.
Use this to set expectations with your provider, not as a goal.
What changes the pace
Four things that shaped results in the trials
Your dose
Higher maintenance doses led to more weight loss on average: 15.0% on 5 mg vs 20.9% on 15 mg.
Type 2 diabetes
People with type 2 diabetes lost less on average: 12.8% on 10 mg and 14.7% on 15 mg in Study 2.
Staying on it
Stopping after 36 weeks led to regaining 14.0% over the next year in Study 4. Continuing led to more loss.
Your habits
Every trial group had diet and activity advice. Protein and strength training help protect muscle as weight comes off.
Stop or continue?
What happened after week 36
| Group | Change |
|---|---|
| Kept taking tirzepatide | −5.5% |
| Switched to placebo | +14.0% |
After 36 weeks on tirzepatide (20.9% lost on average), 670 people were randomly assigned to keep taking it or switch to placebo for 52 more weeks; people who stopped earlier weren’t included. Zepbound label, Table 6.
A price that holds while you do.
$139 a month on a 12-month plan, or $169 month to month, at every dose, so staying on track doesn’t get more expensive as your dose rises.
Check my eligibility
A licensed provider decides if it’s right for you.
Compounded, not FDA-approved: a licensed provider prescribes it only when it offers a significant difference for you.
Two medications.
One flat price each.
Both are prepared by state-licensed 503A partner pharmacies and shipped free. Your provider helps you decide which one fits.
From $119/mo
Semaglutide
Weekly
What’s inside every plan
- Tirzepatide: compounded, weekly, acts on GIP and
GLP-1 - Semaglutide: compounded, weekly, acts on
GLP-1 - Prepared by state-licensed 503A partner pharmacies, with free expedited shipping
- A licensed provider who follows your dose, a nutrition plan and a 1:1 coaching call
- Real people 24/7, physicians during clinical hours, and we handle the pharmacy for you
- HSA and FSA cards, or pay-later options at checkout
- No injections? Ask about the sublingual tablet, at its own flat price
Prescription required. Compounded medications aren’t FDA-approved; a provider prescribes one only when it offers a significant difference for you. Prices checked October 15, 2026.
Your dose goes up.
Your price doesn’t.
No membership, no dose surcharges, no surprises. One flat, all-inclusive monthly price at every dose.
| Month one | Month two | Month three | Every month after | |
|---|---|---|---|---|
| On a 12-month plan | ||||
| Tirzepatide | $139 | $139 | $139 | $139 |
| Semaglutide | $119 | $119 | $119 | $119 |
| Month to month | ||||
| Tirzepatide | $169 | $169 | $169 | $169 |
| Semaglutide | $139 | $139 | $139 | $139 |
Price Match Guarantee. Paying less somewhere else? Send us a receipt from another licensed U.S. telehealth provider or clinic and we’ll match your regular monthly price. See the terms
All-inclusive, the same at every dose. On 3- and 6-month plans, tirzepatide is $159 and $149 a month, and semaglutide is $132 and $125.
What would you pay with NexLife?
Tap where you are now. We’ll show your NexLife price next to it, or tell you we’ll match it.
Pick one above to see your price.
Not today?
Prices from each provider’s own site, checked October 15, 2026. Brand-name and compounded medications are different products: compounded medications aren’t FDA-approved, and a provider prescribes one only when it offers a significant difference for you. †Price Match Guarantee terms apply.
The NexLife Price Match Guarantee
Keep your price.
Upgrade your care.
Already on compounded tirzepatide or semaglutide? Pay less with another licensed U.S. telehealth provider or clinic, and we match your regular monthly price for as long as your plan stays active.† Plus a provider who follows your dose, a nutrition plan, a coaching call and real people 24/7.
- 1Send a receipt from the last 60 days
- 2A NexLife provider reviews your prescription
- 3Pay your matched price, at every dose
Locked while your plan is activeSame price at every doseNo membership fee
†Terms: see the Price Match Guarantee details below. Compounded medications aren’t FDA-approved; a provider prescribes one only when it offers a significant difference for you.
Facts
NexLife at a glance
The facts in one place, as of .
| What NexLife is | A LegitScript-certified telehealth and care-coordination platform. A provider licensed in your state makes every prescribing decision. |
|---|---|
| Medications and prices | Compounded tirzepatide from $139 a month and compounded semaglutide from $119 a month on 12-month plans, or $169 and $139 month to month. The same price at every dose. |
| Included | Provider review, the medication, a personalized nutrition plan, a 1:1 coaching call, free expedited shipping and 24/7 support from real people. No membership fee. |
| Pharmacies | Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL) and Boudreaux’s New Drug Store (Lake Charles, LA): state-licensed 503A partner pharmacies. You never have to contact them; we do. |
| Medical oversight | Medical director Adam Kennah, MD (NPI 1144260043). Physicians answer medical questions during clinical hours. |
| Ratings | 4.8 out of 5 on Trustpilot. 5,000+ members served. |
| Price Match Guarantee | Paying less with another licensed U.S. telehealth provider or clinic? We match your regular all-in monthly price.† |
| Paying | HSA and FSA cards, plus pay-later options at checkout. |
| Important | Compounded medications are not FDA-approved. A provider prescribes one only when it offers a significant difference for you, and not everyone who applies is prescribed. |
| Contact |
Results questions
How fast does tirzepatide work?
Blood levels settle after about 4 weeks on a dose, and doses step up every 4 weeks or more. In the trials, weight loss built over months; results were measured at 72 weeks.
How much weight can I lose on tirzepatide in a month?
The trials reported results at 36 and 72 weeks, not month by month. Averaged over 72 weeks, the 15 mg group’s 20.9% works out to about 0.3% of body weight a week; real loss isn’t that even.
What results can I expect after 3 months?
At 3 months you’re typically still stepping up the dose. The label reports results at 36 and 72 weeks; your provider can tell you what your progress means.
How many people lose 20% on tirzepatide?
In Study 1, 56.7% of people on 15 mg lost at least 20% of their weight by week 72, versus 3.1% on placebo.
What happens if I stop taking tirzepatide?
In Study 4, people switched to placebo after 36 weeks regained 14.0% of their weight over the next year on average, while people who continued lost another 5.5%.
Will compounded tirzepatide give the same results?
Compounded tirzepatide hasn’t been studied in clinical trials and isn’t FDA-approved. These results come from trials of Zepbound.
Important safety information
Compounded tirzepatide and semaglutide are not FDA-approved, and the FDA hasn’t reviewed them for safety, effectiveness or quality. A provider prescribes them only when they offer a significant difference for you compared with an FDA-approved product. Both medicines may cause thyroid tumors, including cancer: don’t use either if you or a family member has had medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2).
Read the full safety information
In studies with rodents, both medicines caused thyroid tumors; it isn’t known whether they cause them in people. Tell your provider if you notice a lump or swelling in your neck, hoarseness, trouble swallowing or shortness of breath. Serious side effects can include inflammation of the pancreas (pancreatitis), gallbladder problems, low blood sugar (especially with insulin or sulfonylureas), kidney problems from dehydration, severe stomach problems, serious allergic reactions, vision changes in people with type 2 diabetes, and a faster heart rate. Tell your care team before any surgery or procedure that uses anesthesia or deep sedation. Don’t combine either medicine with other
Tirzepatide can make birth control pills less effective: switch to a non-oral method, or add a barrier method such as condoms, for 4 weeks after you start and for 4 weeks after each dose increase. Both medicines may harm an unborn baby. Semaglutide should be stopped at least 2 months before a planned pregnancy. Tell your provider right away if you’re pregnant, planning to be, or breastfeeding.
This is a summary, not the complete safety information. Read the full Prescribing Information for FDA-approved tirzepatide (Zepbound) and semaglutide (Wegovy), and talk with your provider. You can report side effects to the FDA at
† NexLife Price Match Guarantee: for new NexLife members switching from a licensed U.S. telehealth provider or clinic with an active prescription for compounded tirzepatide or semaglutide. We match your regular all-in monthly price there (medication plus any required membership, program or visit fee, on a month-to-month plan); first-month offers, coupons, referral credits and prepaid multi-month rates aren’t matched. Proof from the last 60 days required. A licensed provider must determine that treatment is right for you. Not open to people with Medicare, Medicaid or TRICARE coverage. Full terms.
About NexLife. NexLife is a telehealth and care-coordination platform. Care is delivered through affiliated, physician-owned medical groups, and licensed providers decide whether treatment is right for you. NexLife doesn’t make or compound medication: state-licensed partner pharmacies fill each prescription, and we coordinate the rest. Available only in states where our affiliated providers are licensed.
“In this trial, those randomized to receive the highest approved dosage of Zepbound (15 mg once weekly) lost on average 18% of their body weight compared to those randomized to placebo.”
Who checked this page
Adam Kennah, MDMedical Director, NexLife · Board-certified in emergency medicine · NPI 1144260043
Leads the NexLife clinical team, which medically reviewed this page on October 18, 2026.
NexLife editorial teamResearch and pricing
Checked every number against the Zepbound prescribing information (revised August 2026), Tables 2 and 6.
- Every fact, sourced. Each price and rule links to the page it comes from.
- How we make money. NexLife is a telehealth and care-coordination platform. We earn revenue when people join NexLife.
- Corrections, fast. See something wrong or out of date? Email care@nexlife.us and we’ll fix it.
Paying less elsewhere? We match it.†
Results take months. Your price stays put.
Compounded tirzepatide from $139 a month on a 12-month plan, or $169 month to month, at every dose. Start online in about 3 minutes.
4.8 out of 5 on Trustpilot · Medical director Adam Kennah, MD (NPI 1144260043) · LegitScript-certified
Compounded medications aren’t FDA-approved. A provider prescribes one only when it offers a significant difference for you.
- 1Tell us about you
A short online health assessment, about 3 minutes.
- 2A licensed provider reviews it
You’re prescribed only if treatment is right for you.
- 3We ship it, then stay with you
Our partner pharmacy usually ships within 1 to 2 business days. Free shipping, and questions come to us 24/7, never to the pharmacy.
Sources
- Eli Lilly and Company. Zepbound (tirzepatide) prescribing information.
- The New England Journal of Medicine. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1), 2022.
- NexLife. Compounded tirzepatide plans.
- U.S. Food and Drug Administration. FDA’s concerns with unapproved
GLP-1 drugs used for weight loss. - Novo Nordisk. Wegovy (semaglutide) prescribing information.
- LegitScript. LegitScript certification record for NexLife.us.
- NexLife. Compounded semaglutide plans.
- Ro: weight loss program pricing. Checked October 15, 2026.
- Hims: Zepbound KwikPen. Checked October 15, 2026.
- Hims: Wegovy pill and pen, with membership. Checked October 15, 2026.
- Mochi Health: FAQs (membership and medication prices). Checked October 15, 2026.
- Embody: compounded tirzepatide, one-month supply. Checked October 15, 2026.
- Embody: compounded semaglutide, one-month supply. Checked October 15, 2026.